CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
Se Hoon Park, Jeeyun Lee, Tae Sung Sohn, Do Hoon Lim, Kyoung-Mee Kim, Ji Yeong An, Min Gew Choi, Jun Ho Lee, Jae Moon Bae, Sung Kim, Su Jin Lee, Seung Tae Kim, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang
Precis Future Med. 2019;3(1):24-29.   Published online March 13, 2019
DOI: https://doi.org/10.23838/pfm.2018.00177

Excel Download

Results from the safety interim analysis of the adjuvant chemoradiotherapy in stomach tumors 2 trial: a multicenter, randomized phase III clinical trial
Precision and Future Medicine. 2019;3(1):24-29   Crossref logo
Link1 Link2 Link3

P-104 Multi-center phase III trial of Adjuvant Chemoradiotherapy in Stomach Tumors 2 (ARTIST 2)
Annals of Oncology. 2015;26:iv29   Crossref logo
Link1 Link2 Link3

Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery of early-stage breast cancer: final results of the ARCOSEIN trial
Cancer/Radiothérapie. 2007;11(4):225-226   Crossref logo
Link1 Link2

Poor Prognosis Patients with Inoperable Locally Advanced NSCLC and Large Tumors Benefit from Palliative Chemoradiotherapy: A Subset Analysis from a Randomized Clinical Phase III Trial
Journal of Thoracic Oncology. 2014;9(6):825-833   Crossref logo
Link1 Link2

Erratum to: “Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial”
The Journal of Clinical Endocrinology & Metabolism. 2020;105(12):e4986-e4986   Crossref logo
Link1 Link2 Link3

Interim Safety Results From a Randomized Trial of Adjuvant Chemotherapy with Lv5Fu2 Vs. Folfox for Esophageal Squamous Cell Carcinoma
Annals of Oncology. 2013;24:iv53   Crossref logo
Link1 Link2 Link3

Safety results from a pooled analysis of randomized, controlled phase II and III clinical trials and interim data from an open-label extension trial of the interleukin-12/23 monoclonal antibody, briakinumab, in moderate to severe psoriasis
Journal of the European Academy of Dermatology and Venereology. 2012;no-no   Crossref logo
Link1 Link2

Phase III Trial of Concurrent or Sequential Adjuvant Chemoradiotherapy After Conservative Surgery for Early-Stage Breast Cancer: Final Results of the ARCOSEIN Trial
Breast Diseases: A Year Book Quarterly. 2007;18(3):310-311   Crossref logo
Link1 Link2

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial
European Journal of Cancer Supplements. 2009;7(2):324   Crossref logo
Link1 Link2

The evolving role of letrozole in the adjuvant setting: First results from the large, phase III, randomized trial BIG 1-98
The Breast. 2006;15(1):21-29   Crossref logo
Link1 Link2